APLM
APLM
NASDAQ · Biotechnology

Apollomics Inc

$14.51
-1.34 (-8.45%)
As of Apr 1, 4:05 PM ET ·
Financial Highlights (FY 2025)
Revenue
4.59M
Net Income
-196,564
Gross Margin
40.8%
Profit Margin
-4.3%
Rev Growth
+16.2%
D/E Ratio
1.06
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 40.8% 40.8% 40.8%
Operating Margin -4.0% -3.7% -4.4%
Profit Margin -4.3% -4.8% -4.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.59M 4.05M 3.58M
Gross Profit 1.87M 1.65M 1.46M
Operating Income -182,237 -150,486 -157,185
Net Income -196,564 -196,089 -156,693
Gross Margin 40.8% 40.8% 40.8%
Operating Margin -4.0% -3.7% -4.4%
Profit Margin -4.3% -4.8% -4.4%
Rev Growth +16.2% +0.5% -3.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.54M 7.54M 8.50M
Total Equity 8.98M 8.14M 8.85M
D/E Ratio 1.06 0.93 0.96
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -265,994 -241,454 -219,779
Free Cash Flow -252,687 -239,821 -142,632